DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» RNA vaccine
RNA vaccine
Main Outcomes of Discussion of WHO Consultation on Nucleic Acid
Review of COVID-19 Vaccine Subtypes, Efficacy and Geographical Distributions Andre Ian Francis ,1 Saudah Ghany,1 Tia Gilkes,1 Srikanth Umakanthan2
V.5 3/18/2021 1 COVID-19 Vaccine FAQ Sheet
An Update on Self-Amplifying Mrna Vaccine Development
1 Title: Interim Report of a Phase 2 Randomized Trial of a Plant
Download
Revision Rápida
Covid-19 Messenger Rna Vaccine
Candidate SARS-Cov-2 Vaccines in Advanced Clinical Trials: Key Aspects Compiled by John D
Moderna COVID-19 Vaccine Factsheet
Vaccines: Self-Amplifying RNA in Lipid Nanoparticles
Comirnaty, INN-COVID-19 Mrna Vaccine (Nucleoside-Modified)
Pfizer-Biontech COVID-19 Vaccine Bnt162b2
Download Preprint
Interim Recommendations on the Use of COVID-19 Vaccines in Nigeria
Posterserie Impfstoffe Covid-19
An Overview on the Development of Mrna-Based Vaccines and Their Formulation Strategies for Improved Antigen Expression in Vivo
Considerations for Bioanalytical Characterization and Batch Release of COVID-19 Vaccines ✉ Gautam Sanyal 1 , Anna Särnefält 1 and Arun Kumar 1
Top View
2021.06.30.21259439V1.Full.Pdf
Scientific Review of Moderna COVID-19 Vaccine (Mrna-1273) Dec
Neutralizing Activity of BBIBP-Corv Vaccine-Elicited Sera Against Multiple SARS-Cov-2 Variants of Concern
Current State of the First COVID-19 Vaccines
Analysis of SARS-Cov-2 (COVID-19) Vaccine Candidates
An Appraisal of the Current Scenario in Vaccine Research for COVID-19
Economic and Social Council
(COVID-19) Vaccine Candidates
Prevention of COVID-19 in Pregnant Women, Eventual Use of New Vaccines
Coronavirus Vaccine Development: from SARS and MERS to COVID-19
Six Month Safety and Efficacy of the Bnt162b2 Mrna COVID-19 Vaccine
COVID-19 Vaccines: a Review of the Safety and Efficacy of Current
Comparison and Analysis of Neutralizing Antibody Levels in Serum After Inoculating with SARS-Cov-2, MERS-Cov, Or SARS-Cov Vaccines in Humans
Antigen Presentation of Mrna Based and Viral Vector Corona Vaccines
The Vaccine and Sickle Cell Disease Or Thalassaemia
Covid-19 Vaccine Update a Science-Based Overview & Discussion
Background Document on the Mrna Vaccine Bnt162b2 (Pfizer-Biontech) Against COVID-19
Pfizer-Biontech COVID-19 Vaccine VRBPAC Briefing Document
Efficacy and Safety of COVID-19 Vaccines: a Systematic Review and Meta-Analysis of Randomized Clinical Trials
Conceptual Analysis of COVID-19 in Phase 3 Clinical Trials
A Minireview of the Promising Drugs and Vaccines in Pipeline for the Treatment of COVID-19 and Current Update on Clinical Trials
SARS-Cov-2 Vaccine Development and How Brazil Is Contributing
Adenoviral Vector Vaccine Platforms in the SARS-Cov-2 Pandemic ✉ Samir Andrade Mendonça1, Reka Lorincz1, Paul Boucher1 and David T
Protocol C4591001
COVID-19 Mrna VACCINE RISK MANAGEMENT PLAN (RMP)
RNA Vaccines: an Introduction October 2018 Laura Blackburn
Immunological Mechanisms of Vaccine-Induced Protection Against COVID-19 in Humans
(COVID-19) Vaccine Efficacy and Effectiveness to Inform Simulation Studies of Vaccine Impact: a Systematic Review [Version 1; Peer Review: Awaiting Peer Review]
Pfizer/Biontech COVID-19 Mrna Vaccine-Overview for ACIP Meeting
Greenbook Chapter 14A Covid-19 – SARS-Cov-2, Gov.UK
Review of COVID‑19 Vaccine
Antigen Presentation of Mrna-Based and Virus-Vectored SARS-Cov-2 Vaccines
RNA COVID-19 Vaccine (Pfizer Or Moderna)
The COVID-19 Vaccines: Recent Development, Challenges and Prospects
COVID-19 Vaccines Currently Under Preclinical and Clinical Studies, and Associated Antiviral Immune Response
Study of Awareness Regarding Covid-19 Vaccines Among General Population
SARS-Cov-2 Mrna Vaccines: Immunological Mechanism and Beyond
Characterizing Cellular and Molecular Variabilities of Peripheral Immune
Analysis of SARS-Cov-2 (COVID-19) Vaccine Candidates
Efficacy and Landscape of Covid-19 Vaccines: a Review Article
Overview of Data to Inform Recommendations for Booster Doses of COVID-19 Vaccines
Insight Into COVID-19 Available Vaccines Authorised for Emergency Use Nuha A
SARS-Cov-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines
Oxford Covid Vaccine Results Puzzle Scientists
Mrna-Based Vaccines
Pfizer-Biontech Covid-19 Vaccine – Day 21 Dosing
COVID-19 VACCINES Based on Available Evidence up to 16 November 2020
COVID-19 Vaccine Candidates
Safety and Potency of Coviran Barekat Inactivated Vaccine Candidate for SARS-Cov-2: a Preclinical Study
Status Report on COVID-19 Vaccines Development
Current Updates on Covid-19 Vaccines
COVID-19 Vaccine Overview Immunisation Coalition Annual Scientific Meeting Sunday 7Th Feb 2021
IP Trends on COVID-19 Vaccine-Related Patents
FINLAY-FR-2 Nombre Comercial: SOBERANA02 Código Del Protocolo: IFV/COR/06
The COVID-19 Vaccines: Recent Development, Challenges and Prospects